Menu
A Canada based biopharmaceutical company focused on the rapid development and production of specialty antibody and protein drugs.
The business was seeking early stage investment for growth.
Ruffena introduced an angel investor at a very early stage, facilitating the investment needed for the company to develop and build on its pipeline of life-saving medicines.
With its innovative development of antibody and protein drugs, the team have have since established different lines of revenue in distinct areas; these include national defence agencies, health agencies and biosimilar pharmaceutical companies.
A Canada based biopharmaceutical company focused on the rapid development and production of specialty antibody and protein drugs.
The business was seeking early stage investment for growth.
Ruffena introduced an angel investor at a very early stage, facilitating the investment needed for the company to develop and build on its pipeline of life-saving medicines.
With its innovative development of antibody and protein drugs, the team have have since established different lines of revenue in distinct areas; these include national defence agencies, health agencies and biosimilar pharmaceutical companies.